C127H151Cl2F5N18O13 — CID 158388639
(3S)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-difluorocyclopentane-1-carboxamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]spiro[2.3]hexane-2-carboxamide;N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide (PubChem CID 158388639) has the molecular formula C127H151Cl2F5N18O13 and a molecular weight of 2303.61 g/mol. Its IUPAC name is (3S)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-difluorocyclopentane-1-carboxamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]spiro[2.3]hexane-2-carboxamide;N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide.
| Compound Name | (3S)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-difluorocyclopentane-1-carboxamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]spiro[2.3]hexane-2-carboxamide;N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide |
|---|---|
| PubChem CID | 158388639 |
| Molecular Formula | C127H151Cl2F5N18O13 |
| Molecular Weight | 2303.61 g/mol |
| Exact Mass | 2301.10 |
| IUPAC Name | (3S)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(6-chloro-1-cyclobutylbenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]-3,3-difluorocyclopentane-1-carboxamide;N-[1-cyclobutyl-6-(2-hydroxypropan-2-yl)benzimidazol-2-yl]spiro[2.3]hexane-2-carboxamide;N-[1-cyclobutyl-6-(trifluoromethyl)benzimidazol-2-yl]-3,3-dicyclopropyl-3-hydroxypropanamide |
| SMILES | CC(C)(O)c1ccc2nc(NC(=O)C3CC34CCC4)n(C3CCC3)c2c1.CC(C)(O)c1ccc2nc(NC(=O)C3CCC(F)(F)C3)n(C3CCC3)c2c1.CC(C)(O)c1ccc2nc(NC(=O)CC(O)(C3CC3)C3CC3)n(C3CCC3)c2c1.C[C@@](O)(CC(=O)Nc1nc2ccc(Cl)cc2n1C1CCC1)c1ccccc1.C[C@](O)(CC(=O)Nc1nc2ccc(Cl)cc2n1C1CCC1)c1ccccc1.O=C(CC(O)(C1CC1)C1CC1)Nc1nc2ccc(C(F)(F)F)cc2n1C1CCC1 |
| InChI | InChI=1S/C23H31N3O3.2C21H22ClN3O2.C21H24F3N3O2.C21H27N3O2.C20H25F2N3O2/c1-22(2,28)16-10-11-18-19(12-16)26(17-4-3-5-17)21(24-18)25-20(27)13-23(29,14-6-7-14)15-8-9-15;2*1-21(27,14-6-3-2-4-7-14)13-19(26)24-20-23-17-11-10-15(22)12-18(17)25(20)16-8-5-9-16;22-21(23,24)14-8-9-16-17(10-14)27(15-2-1-3-15)19(25-16)26-18(28)11-20(29,12-4-5-12)13-6-7-13;1-20(2,26)13-7-8-16-17(11-13)24(14-5-3-6-14)19(22-16)23-18(25)15-12-21(15)9-4-10-21;1-19(2,27)13-6-7-15-16(10-13)25(14-4-3-5-14)18(23-15)24-17(26)12-8-9-20(21,22)11-12/h10-12,14-15,17,28-29H,3-9,13H2,1-2H3,(H,24,25,27);2*2-4,6-7,10-12,16,27H,5,8-9,13H2,1H3,(H,23,24,26);8-10,12-13,15,29H,1-7,11H2,(H,25,26,28);7-8,11,14-15,26H,3-6,9-10,12H2,1-2H3,(H,22,23,25);6-7,10,12,14,27H,3-5,8-9,11H2,1-2H3,(H,23,24,26)/t;2*21-;;;/m.10.../s1 |
| InChIKey | GWRANPRPAUBYHM-SJNQVXKNSA-N |
| XLogP | 26.31 |
| TPSA | 423.13 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2303.61 |
| LogP ≤ 5 | 26.31 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 25 |